As the primary component of the amyloid plaques seen in the brains of Alzheimer patients, amyloid- (A) refers to peptides of 36–43 amino acids that are crucially involved in Alzheimer's disease. The amyloid precursor protein (APP), which is cut by specific enzymes to produce A, produces the peptides. Amyloid molecules can group together to create a variety of flexible, soluble oligomers.A amyloid-peptide buildup results from excessive A production or malfunctioning clearance mechanisms. Amyloid- forms diffuse and neuritic plaques in the parenchyma and blood vessels by self-aggregating into oligomers of various sizes. Strong synaptotoxins, proteasome inhibition, mitochondrial inhibition, alteration of intracellular Ca2+ levels, and induction of inflammatory processes are all characteristics of amyloid-oligomers and plaques. Neuronal dysfunction is also thought to be influenced by the loss of A's typical physiological functions.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V110818 | Aβ aggregation-IN-3 | Aβ aggregation inhibitor-IN-3 (compound B7) is an Aβ aggregation inhibitor. | |
|
V111796 | Aβ aggregation-IN-4 | 603113-07-1 | The Aβ aggregation inhibitor IN-4 can alleviate the neurotoxicity of β-amyloid (Aβ) and significantly reduce the level of Aβ oligomer complexes (Aβ-OCs). |
|
V109160 | Aβ aggregation-IN-5 | The Aβ aggregation inhibitor IN-5 is an amyloid-β protein aggregation inhibitor that can cross the blood-brain barrier. | |
|
V71395 | Aβ Fibrillization modulator 1 | 2847131-53-5 | Aβ Fibrillization modulator 1 can stabilize Aβ monomer. |
|
V93241 | Aβ-IN-10 | Aβ-IN-10 (compound Alz-5) is a bifunctional copper chelator and an inhibitor of amyloid-β (Aβ), which can interact with Aβ aggregates and reduce their neurotoxicity. | |
|
V78525 | Aβ-IN-6 | Aβ-IN-6 reduces proinflammatory cytokine release from microglia. | |
|
V78330 | Aβ-IN-7 | Aβ-IN-7 (compound 5a) is a potent inhibitor of Aβ aggregation. | |
|
V78331 | Aβ-IN-8 | Aβ-IN-8 (compound 7e) is a potent inhibitor of Aβ aggregation. | |
|
V102240 | Aβ-IN-9 | Aβ-IN-9 (compound 6i) is an amyloid β protein (Aβ) aggregation inhibitor. | |
|
V71369 | Aβ/tau aggregation-IN-1 | 2252162-81-3 | Aβ/tau aggregation-IN-1 is a potent inhibitor of Aβ1-42 β-sheets formation and tau aggregation. |
|
V71416 | Aβ/tau aggregation-IN-3 | 1210750-32-5 | Aβ/tau aggregation-IN-3 is a potent amyloid aggregation inhibitor (antagonist) with IC50 of 0.85 μM as measured by Aβ-thioflavin T (Aβ-ThT) functional aggregation. |
|
V87775 | Aβ1-14-εK-KKK-MvF5 Th acetate | Aβ1-14-εK-KKK-MvF5 Th acetate is the acetate form of Aβ1-14-εK-KKK-MvF5 Th. | |
|
V85063 | Aβ1–42 aggregation inhibitor 2 | ||
|
V71390 | Aβ42 agonist-1 | 50635-12-6 | Aβ42 agonist-1 (compound 7a) is a small molecule compound that can promote Aβ42 aggregation. |
|
V71376 | Aβ42 agonist-2 | 6314-40-5 | Aβ42 agonist-2 (compound 7b) is a small molecule compound that can promote Aβ42 aggregation. |
|
V85095 | Aβ42-IN-4 | 2387822-02-6 | |
|
V84203 | Aβ42-IN-5 | ||
|
V71445 | Beta-Amyloid (15-21) (Beta-Amyloid (15-21)) | 365537-52-6 | β-amyloid (15-21) is a fragment of the β-amyloid peptide with potential role in the neurological field. |
|
V71413 | BIBD-124 | 2716871-93-9 | BIBD-124 binds amyloid (Aβ) plaques with IC50 of 9.51 nM. |
|
V71405 | Biotin-Ahx-β-Amyloid (1-40) | 1802086-72-1 | Biotin-Ahx-β-Amyloid (1-40) is a biologically active peptide. |